DUBLIN, March 15, 2019 — The “Bioreactors Market to 2027- Global Analysis and Forecasts by Product Class; Application; Process; and Geography” report has been added to ResearchAndMarkets.com’s offering.
The global bioreactors market is expected to reach US$ 4,811.5 Mn in 2027 from US$ 2,850.2 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.
The growth of the bioreactors market is primarily attributed to the increasing investments in R&D and other activities. Moreover, the rapid growth of pharmaceutical and biotechnology industry is also expected to drive the growth of bioreactors market. However, availability of alternative techniques for bioreactors and stringent regulatory framework is expected to obstruct the growth of bioreactors market.
On the other hand, rapid use of single use bioreactors are expected to be trending in the manufacturing companies and research institutes in the market. The single-use bioreactors are helpful in providing next-generation cell- and gene-therapies and continuous bioprocessing. The betterments and improvements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of single-use bioreactors through reductions in needed reactor volumes.
Single-use bioreactors reduce the risks of contamination from the other products and decrease production turnaround times. Moreover, reduction in validation time shortens time which is a tremendous value for the advanced development of the bio products. The S.U.B. combines elements of stirred-tank systems with the efficiencies in cleanup and validation found in single-use processing, and supports scale-up needs and optimal cell growth, viability, and general metabolism.
In 2018, the industrial scale (>1000L) bioreactors segment held a largest market share of 63.4% of the bioreactors market, by product class. This segment is also expected to dominate the market in 2027 owing to increasing demand for industrial scale (>1000L) bioreactors in biotechnology and pharmaceutical companies. However, the pilot scale (15 – 1000L) bioreactors segment is anticipated to witness the fastest growth rate of 6.8% during the forecast period, 2019 to 2027 owing to the increased use of pilot scale bioreactors for research purposes.
Global bioreactors market, based on application was segmented into microbial application and cell culture. Microbial application segment is anticipated to grow at a CAGR of 6.5% during the forecast period. The production of microbiologic and increasing government funding as well as promotional initiatives undertaken for usage of microbial products to treat medical conditions. Increasing R&D innovation in various other microbial applications has also been contributing significantly to the growth of the bioreactors market.
Some of the major primary and secondary sources for bioreactors included in the report are World Health Organization (WHO), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), National Research Foundation (NRF), Biotechnology Industry Research Assistance Council (BIRAC), Canadian Institutes of Health Research (CIHR) and others.
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Bioreactors Market – by Product Class
1.3.2 Global Bioreactors Market – by Application
1.3.3 Global Bioreactors Market – by Process
1.3.4 Global Bioreactors Market – by Geography
2. Global Bioreactors Market – Key Takeaways
3. Research Methodology
3.1.2 Secondary Research
3.1.3 Primary Research
4. Global Bioreactors Market – Market Landscape
4.2 Pest Analysis
4.2.1 North America – Pest Analysis
4.2.2 Europe – Pest Analysis
4.2.3 Asia Pacific – Pest Analysis
4.2.4 Middle East & South Africa – Pest Analysis
4.2.5 South and Central America – Pest Analysis
5. Global Bioreactors Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increased Acceptance of Single-Use Bioreactors
5.1.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
5.1.3 Increasing Investments In R&D and Other Activities
5.1.4 Technological Advancements In Bioreactors
5.2 Key Market Restraints
5.2.1 Stringent Regulatory Framework
5.2.2 Availability of Alternative Techniques For Bioreactors
5.3 Key Market Opportunities
5.3.1 High Market Potential In Emerging Economies
5.3.2 Rising Demand of Personalized Medicine
5.4 Future Trends
5.4.1 Rapid Adoption of Ionic Liquids
5.5 Impact Analysis
6. Bioreactors Market – Global Analysis
6.1 Global Bioreactors Market Revenue Forecasts and Analysis
6.2 Global Bioreactors Market, by Geography – Forecasts and Analysis
6.3 Performance of Key Players
6.3.1 Merck KGaA
6.3.2 Applikon Biotechnology B.V.
6.3.3 Thermo Fisher Scientific Inc.
6.4 Expert Opinions
7. Global Bioreactors Market Analysis – by Product Class
7.2 Global Bioreactors Market by Product Class, 2018 & 2027 (%)
7.3 Benchtop Bioreactors (Up To 15L) Market
7.4 Pilot Scale Bioreactors (15-1000L) Market
7.5 Industrial Scale Bioreactors (>1000L) Market
8. Global Bioreactors Market Analysis – by Application
8.2 Global Bioreactors Market, by Application 2018 & 2027 (%)
8.3 Microbial Application Market
8.4 Cell Culture Market
9. Global Bioreactors Market Analysis – by Process
9.2 Global Bioreactors Market, by Process 2018 & 2027 (%)
9.3 Research & Development Market
9.4 Process Development Market
9.5 Bioproduction Market
10. Bioreactors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Bioreactors Market
10.2 Europe Bioreactors Market
10.3 Asia Pacific Bioreactors Market
10.4 Middle East & Africa Bioreactors Market
10.5 South and Central America Bioreactors Market
11. Bioreactors Market – Industry Landscape
11.2 Comparative Company Analysis
11.3 Growth Strategies In the Bioreactors Market, 2015-2018
11.4 Organic Growth Strategies
11.4.3 Product Launches
11.4.4 Other Organic Growth Strategies
11.5 Inorganic Growth Strategies
11.5.4 Other Inorganic Growth Strategies
12. Bioreactors Market – Key Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Applikon Biotechnology B.V.
12.3 Thermo Fisher Scientific Inc.
12.5 Bioengineering AG
12.6 Solaris Biotechnology Srl
12.7 Praj Industries
12.8 Sartorius AG
12.9 Danaher (Pall Corporation)
12.10 General Electric
For more information about this report visit
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets